SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-20-000124
Filing Date
2020-07-29
Accepted
2020-07-29 06:07:47
Documents
7
Period of Report
2020-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k-072920.htm 6-K 454874
2 GRAPHIC image11.jpg GRAPHIC 31064
3 GRAPHIC image21.jpg GRAPHIC 15406
4 GRAPHIC image31.jpg GRAPHIC 15813
5 GRAPHIC image8611.jpg GRAPHIC 22116
6 GRAPHIC image8711.jpg GRAPHIC 28803
7 newbitmapimage11.jpg GRAPHIC 204282
  Complete submission text file 0001395064-20-000124.txt   893780
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 201055626
SIC: 2834 Pharmaceutical Preparations